- Home
- PMM vs AQST Comparison
PMM vs AQST Comparison
Compare PMM & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMM
- AQST
- Stock Information
- Founded
- PMM 1989
- AQST 2004
- Country
- PMM United States
- AQST United States
- Employees
- PMM N/A
- AQST 135
- Industry
- PMM Investment Managers
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- PMM Finance
- AQST Health Care
- Exchange
- PMM Nasdaq
- AQST Nasdaq
- Market Cap
- PMM 284.9M
- AQST 274.4M
- IPO Year
- PMM N/A
- AQST 2018
- Fundamental
- Price
- PMM $6.34
- AQST $3.01
- Analyst Decision
- PMM
- AQST Strong Buy
- Analyst Count
- PMM 0
- AQST 8
- Target Price
- PMM N/A
- AQST $10.38
- AVG Volume (30 Days)
- PMM 118.3K
- AQST 2.0M
- Earning Date
- PMM 01-01-0001
- AQST 03-05-2025
- Dividend Yield
- PMM 4.68%
- AQST N/A
- EPS Growth
- PMM N/A
- AQST N/A
- EPS
- PMM 0.23
- AQST N/A
- Revenue
- PMM N/A
- AQST $58,900,000.00
- Revenue This Year
- PMM N/A
- AQST $18.44
- Revenue Next Year
- PMM N/A
- AQST N/A
- P/E Ratio
- PMM $26.52
- AQST N/A
- Revenue Growth
- PMM N/A
- AQST 22.56
- 52 Week Low
- PMM $5.00
- AQST $2.24
- 52 Week High
- PMM $6.42
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- PMM 61.45
- AQST 43.29
- Support Level
- PMM $6.14
- AQST $2.95
- Resistance Level
- PMM $6.42
- AQST $3.21
- Average True Range (ATR)
- PMM 0.07
- AQST 0.20
- MACD
- PMM 0.01
- AQST 0.02
- Stochastic Oscillator
- PMM 71.43
- AQST 18.42
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.